Literature DB >> 16248379

Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT.

Kazuki Ito1, Hiroki Sugihara, Noriyuki Kinoshita, Akihiro Azuma, Hiroaki Matsubara.   

Abstract

UNLABELLED: We compared Takotsubo cardiomyopathy (transient left ventricular apical ballooning) with acute myocardial infarction (AMI) using two-dimensional echocardiography, 99mTc-tetrofosmin, 99mTc-PYP, 123I-BMIPP and 123I-MIBG myocardial SPECT.
METHODS: We examined 7 patients with Takotsubo cardiomyopathy and 7 with AMI at the time of emergency admission (acute phase), and 2-14 days (subacute phase), one month (chronic phase), and 3 months (chronic II phase) after the attack. The left ventricle was divided into nine regions on echocardiograms and SPECT images, and the degree of abnormalities in each region was scored according to five grades from normal (0) to severely abnormal (4).
RESULTS: Coronary angiography showed the absence of stenotic regions in patients with Takotsubo cardiomyopathy, and severely stenotic and/or occlusive lesions in patients with AMI. The total ST segment elevation on electrocardiograms (mm) was 7.8 +/- 3.7 in those with Takotsubo cardiomyopathy, and 7.3 +/- 3.9 in patients with AMI. Abnormal wall motion scores on echocardiograms were 14.2 +/- 4.6, 4.7 +/- 4.0, 1.7 +/- 2.0 and 0.5 +/- 0.4 during the acute, subacute, chronic and chronic II phases, respectively, in patients with Takotsubo cardiomyopathy, and 14.0 +/- 4.3, 11.4 +/- 3.9, 8.8 +/- 3.6 and 5.2 +/- 4.8 in those with AMI. Abnormal myocardial perfusion scores on 99mTc-tetrofosmin images were 11.8 +/- 3.5, 3.2 +/- 3.0, 0.5 +/- 1.2 and 0.2 +/- 0.4 during the acute, subacute, chronic and chronic II phases, in patients with Takotsubo cardiomyopathy, and 16.2 +/- 4.3, 13.9 +/- 4.6, 7.9 +/- 4.6 and 5.0 +/- 4.5, respectively, in those with AMI. Abnormal myocardial fatty acid scores on 123I-BMIPP images were 12.6 +/- 3.7, 6.8 +/- 3.2 and 0.4 +/- 0.6 during the subacute, chronic and chronic II phases, respectively, in patients with Takotsubo cardiomyopathy, and 16.5 +/- 5.1, 14.7 +/- 4.8 and 7.5 +/- 4.5 in those with AMI. Abnormal myocardial sympathetic nerve function scores on 123I-MIBG images were 14.8 +/- 4.0, 8.8 +/- 4.0 and 0.4 +/- 0.6 during the subacute, chronic, chronic II phases, respectively, in patients with Takotsubo cardiomyopathy, and 18.6 +/- 6.5, 16.8 +/- 6.8 and 12.9 +/- 5.2 in those with AMI. Myocardial 99mTc-PYP uptake was abnormal not only in patients with AMI but also in those with Takotsubo cardiomyopathy during the acute phase.
CONCLUSIONS: Takotsubo cardiomyopathy might represent a stunned myocardium caused by a disturbance of the coronary microcirculation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248379     DOI: 10.1007/bf02985570

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  25 in total

Review 1.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

2.  Reverse Takotsubo syndrome diagnosed with Tc-99m SPECT perfusion study.

Authors:  Michael Davis; Charles Hardebeck
Journal:  J Nucl Cardiol       Date:  2009-05-14       Impact factor: 5.952

Review 3.  The role of multimodality imaging in takotsubo cardiomyopathy.

Authors:  Osamu Manabe; Masanao Naya; Noriko Oyama-Manabe; Kazuhiro Koyanagawa; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2018-06-01       Impact factor: 5.952

Review 4.  Non-invasive imaging of microvascular damage.

Authors:  L Galiuto; L Natale; L Leccisotti; G Locorotondo; A Giordano; L Bonomo; F Crea
Journal:  J Nucl Cardiol       Date:  2009-08-25       Impact factor: 5.952

Review 5.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

6.  Tako-tsubo cardiomyopathy and microcirculation.

Authors:  Giovanni Fazio; Filippo M Sarullo; Giuseppina Novo; Salvatore Evola; Monica Lunetta; Giuseppe Barbaro; Francesca Sconci; Salvatore Azzarelli; Yoshihiro Akashi; Francesco Fedele; Salvatore Novo
Journal:  J Clin Monit Comput       Date:  2010-01-08       Impact factor: 2.502

Review 7.  Takotsubo syndrome: Advances in the understanding and management of an enigmatic stress cardiomyopathy.

Authors:  Hernán David Mejía-Rentería; Iván J Núñez-Gil
Journal:  World J Cardiol       Date:  2016-07-26

Review 8.  Novel aspects of glypican glycobiology.

Authors:  L-A Fransson; M Belting; F Cheng; M Jönsson; K Mani; S Sandgren
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 9.  Stress cardiomyopathy syndrome: a contemporary review.

Authors:  Divya Kapoor; Kevin A Bybee
Journal:  Curr Heart Fail Rep       Date:  2009-12

10.  Persisting myocardial sympathetic dysfunction in takotsubo cardiomyopathy.

Authors:  Hein J Verberne; Dirk J van der Heijden; Berthe L F van Eck-Smit; G Aernout Somsen
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.